Professor Farzin Farzaneh

King’s College London
Professor of Molecular Medicine, Director of Cell and Gene Therapy

Farzin Farzaneh D.Phil., FRCPath., FRSB
Professor of Molecular Medicine, and Director of Cell and Gene Therapy – King’s.
Consultant in Specialist Medicine, King’s College Hospital

Farzin Farzaneh holds the Chair of Molecular Medicine at King’s College London. He has published over 250 research articles with an average citation of over 30, and an Impact Factor of 47. He has run a licensed GMP facility at King’s College London, since 2001, for the production of cell and gene therapy based investigational medicinal products. Farzin has extensive industrial and academic collaborations, including research council, charitable and pharmaceutical sponsorships of over £25M. He is appointed by the Commission on Human Medicines, as a member of the Clinical Trials, Biologicals & Vaccines Expert Advisory Group since 2016. He is the recipient of 2016 Distinguished Scientist Award of the US Society for Experimental Biology & Medicine.

dont miss

Advanced Therapy Medicinal Products (ATMPs) for achievement of deeper and longer lasting immune mediated cancer remission

Cell and gene based therapy of cancer is making major improvements to the treatment of cancer. The development of new strategies for the development of chimeric antigen receptor T cells, genetically modified cancer cell vaccines and therapeutic cancer vaccines for the specific induction of cellular immunity will be described.

EVEN MORE SEMINARS

  • Luca Boldrini: Speaking at the Oncology Convention

    Luca Boldrini
    Università Cattolica del Sacro Cuore, Roma, Italia

    Radiomics applications rectal cancer: the MRIdian perspective

  • Professor Farzin Farzaneh: Speaking at the Oncology Convention

    Professor Farzin Farzaneh
    King’s College London

    Advanced Therapy Medicinal Products (ATMPs) for achievement of deeper and longer lasting immune mediated cancer remission

  • Andras Szasz: Speaking at the Oncology Convention

    Andras Szasz
    St. Istvan University

    Modulated electrohyperthermia (mEHT) for advanced malignant tumors

  • Dr. Anna ME Bruynzeel: Speaking at the Oncology Convention

    Dr. Anna ME Bruynzeel
    Amsterdam UMC (formerly VUmc)

    MR Guided Adaptive Radiation Therapy; three years of clinical experience at VUmc

  • Dr. Matthew Prime: Speaking at the Oncology Convention

    Dr. Matthew Prime
    Roche Diagnostics Information Solutions

    Personalized healthcare: Leveraging data to improve patient care through clinical decision support in oncology